AMPH
Amphastar Pharmaceuticals, Inc.
25.40$
-0.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.4% | -3.5% | +6.1% | +3.5% | -1.2% | -8.6% | +2.3% | +10.0% | -4.6% | -6.5% | +7.4% | – | |
| – | +13.6% | +3.1% | +3.2% | -0.4% | +15.0% | -14.6% | +3.1% | +6.0% | +4.6% | +3.5% | -10.3% | – | |
| – | -11.3% | -9.2% | +9.0% | +7.1% | -15.0% | -1.6% | +1.5% | +14.1% | -13.2% | -17.9% | +32.9% | – | |
| – | +22.5% | -30.3% | +24.0% | +19.4% | -13.9% | +10.8% | -0.1% | +11.3% | +4.3% | +14.7% | -17.1% | – | |
| – | +3.7% | +19.5% | -15.3% | +11.6% | -12.7% | +23.6% | -12.5% | +182.1% | -58.3% | +9.5% | +1.2% | – | |
| – | +18.0% | -6.8% | +1.7% | +12.4% | -7.5% | +15.6% | -7.6% | +65.5% | -31.7% | +13.2% | -5.2% | – | |
| – | -25.7% | -11.1% | +15.0% | +3.3% | -20.9% | -17.4% | +13.1% | -40.0% | +40.6% | -61.7% | +191.5% | – | |
| – | -31.0% | -8.9% | 0.0% | -22.2% | -4.1% | -2.2% | -0.1% | +0.0% | +5.5% | -1.2% | +1.6% | – | |
| – | -35.4% | +15.8% | +6.2% | -5.1% | -7.8% | -29.8% | +27.5% | -45.3% | +48.3% | -68.5% | +283.4% | – | |
| – | -66.7% | -11.7% | +198.0% | -41.0% | -17.3% | -7.0% | +48.9% | -49.9% | +79.8% | -51.5% | +125.7% | – | |
| – | -26.5% | +19.4% | -12.1% | +6.5% | -6.1% | -33.4% | +22.7% | -44.1% | +40.8% | -73.7% | +372.7% | – | |
| – | -29.0% | +8.2% | +4.5% | -5.7% | -5.5% | -19.5% | +18.1% | -32.2% | +30.1% | -39.3% | +36.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.